다우존스 지수

실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

등록

GERN

Geron (GERN)

Geron Corp

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GERN

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/12	05:54	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GERN	Geron Corp
2025/03/03	20:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GERN	Geron Corp
2025/03/03	20:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GERN	Geron Corp
2025/03/03	20:01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GERN	Geron Corp
2025/02/26	21:30	Business Wire	Geron Corporation Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights	NASDAQ:GERN	Geron Corp
2025/02/21	23:00	Business Wire	Geron to Participate at Upcoming Investor Conferences in March 2025	NASDAQ:GERN	Geron Corp
2025/02/20	06:15	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2025/02/03	23:00	Business Wire	Geron to Announce Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025	NASDAQ:GERN	Geron Corp
2025/01/22	06:30	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2025/01/13	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GERN	Geron Corp
2025/01/11	06:05	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:GERN	Geron Corp
2025/01/03	06:05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GERN	Geron Corp
2024/12/20	06:30	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2024/12/13	20:36	Business Wire	Geron Announces Positive CHMP Opinion for RYTELO™ (imetelstat) for the Treatment of Adults with Transfusion-Dependent Anemia due to Lower-Risk MDS	NASDAQ:GERN	Geron Corp
2024/12/10	23:00	Business Wire	Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies	NASDAQ:GERN	Geron Corp
2024/12/10	23:00	Business Wire	Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis	NASDAQ:GERN	Geron Corp
2024/11/27	23:00	Business Wire	Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference	NASDAQ:GERN	Geron Corp
2024/11/22	06:30	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2024/11/14	23:31	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:GERN	Geron Corp
2024/11/14	20:25	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:GERN	Geron Corp
2024/11/12	06:30	Business Wire	Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development	NASDAQ:GERN	Geron Corp
2024/11/11	23:00	Business Wire	Geron to Participate in the Stifel 2024 Healthcare Conference	NASDAQ:GERN	Geron Corp
2024/11/07	21:10	GlobeNewswire Inc.	Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million	NASDAQ:GERN	Geron Corp
2024/11/07	21:01	Business Wire	Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors	NASDAQ:GERN	Geron Corp
2024/11/07	21:00	Business Wire	Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:GERN	Geron Corp
2024/11/05	23:00	Business Wire	Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies	NASDAQ:GERN	Geron Corp
2024/10/18	05:30	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2024/10/16	05:30	Business Wire	Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024	NASDAQ:GERN	Geron Corp
2024/09/20	05:30	Business Wire	Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GERN	Geron Corp
2024/09/10	05:35	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:GERN	Geron Corp

검색 관련기사 보기:NASDAQ:GERN

1 2 3 4 5 6 7 8 9 10 다음 >>

Hellenic Corporate Bond ...

First Fed Bancorp

Bnp Paribas Issuance

Exail Technologies

Leonteq Securities

Advantagewon Oil (CE)

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관